table_specific

What was the median sales for the mid-lower 25% of Learningrx centers in the sample?

Learningrx Franchise · 2025 FDD

Answer from 2025 FDD Document

Sample: Top 25% Mid-Top Mid-Lower Bottom
25% 25% 25%
# of Centers: 11 10 10 10 4
Top Sales $893,375 $486,808 $287,188 $167,835 $376,730
Low Sales $507,737 $300,712 $172,105 $35,673 $133,094
Median Sales $601,971 $391,046 $229,711 $75,215 $195,526
Average Sales $631,577 $402,343 $229,935 $85,218 $225,219
Centers meeting or 2 / 18% 5 / 50% 5 / 50% 3 / 30% 1 / 25%
exceeding average:

Source: Item 19 — FINANCIAL PERFORMANCE REPRESENTATIONS (FDD pages 46–48)

What This Means (2025 FDD)

According to Learningrx's 2025 Franchise Disclosure Document, the median sales for the mid-lower 25% of centers in the sample was $229,711. This data is based on the performance of 45 franchised Learningrx centers that had complete data and were open for the full 12 months during the fiscal year ending September 30, 2024. The centers were divided into quartiles based on their total revenues. The mid-lower 25% represents the third quartile of centers.

For a prospective Learningrx franchisee, this figure provides an indication of the potential revenue that can be generated by a center performing in the third quartile. It's important to note that this is just a representation of past performance and there is no guarantee that a new franchisee will achieve the same results. Factors such as location, market conditions, and the franchisee's management skills can all impact the actual revenue generated.

It is also important to consider the range of sales within this quartile. The top sales for the mid-lower 25% was $287,188, while the low sales was $172,105. This indicates that there is a significant variation in performance within this group. Prospective franchisees should carefully consider these figures and conduct their own research to determine the potential revenue that they can realistically expect to generate. Learningrx also states that written substantiation for the financial performance representation will be made available to the prospective franchisee upon reasonable request.

Disclaimer: This information is extracted from the 2025 Franchise Disclosure Document and is provided for research purposes only. It does not constitute legal or financial advice. Consult with a franchise attorney before making any investment decisions.